Advertisement

Topics

ESMO 2017: DNA sequencing could open up new drug indications for patients with rare cancers

22:06 EDT 7 Sep 2017 | ecancermedicalscience

Thanks to DNA sequencing, patients with rare cancers for which no standard treatment is available could receive existing therapies that work in patients treated for different cancers, but who carry the same genetic mutations. The first results of a...

Original Article: ESMO 2017: DNA sequencing could open up new drug indications for patients with rare cancers

NEXT ARTICLE

More From BioPortfolio on "ESMO 2017: DNA sequencing could open up new drug indications for patients with rare cancers"

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...